Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Embolism | 7 | 2020 | 222 | 4.000 |
Why?
|
| Diagnostic Errors | 5 | 2022 | 160 | 2.270 |
Why?
|
| Intensive Care Units | 6 | 2023 | 373 | 2.270 |
Why?
|
| Critical Illness | 5 | 2022 | 294 | 2.190 |
Why?
|
| Problem Solving | 4 | 2023 | 54 | 1.660 |
Why?
|
| Physical Examination | 3 | 2018 | 149 | 1.570 |
Why?
|
| Sepsis | 3 | 2019 | 306 | 1.540 |
Why?
|
| Clinical Competence | 5 | 2019 | 751 | 1.530 |
Why?
|
| Shock, Septic | 2 | 2019 | 102 | 1.290 |
Why?
|
| Echocardiography | 5 | 2020 | 911 | 1.280 |
Why?
|
| Thinking | 2 | 2018 | 33 | 1.270 |
Why?
|
| Anti-Bacterial Agents | 4 | 2022 | 746 | 1.220 |
Why?
|
| Internal Medicine | 4 | 2019 | 347 | 1.120 |
Why?
|
| Teaching Rounds | 2 | 2018 | 24 | 1.100 |
Why?
|
| Acute Disease | 4 | 2020 | 826 | 1.070 |
Why?
|
| Decision Making | 3 | 2019 | 642 | 0.980 |
Why?
|
| Humans | 42 | 2023 | 86643 | 0.860 |
Why?
|
| Education, Medical | 4 | 2020 | 233 | 0.830 |
Why?
|
| Antimicrobial Stewardship | 1 | 2022 | 21 | 0.830 |
Why?
|
| Epidemics | 1 | 2022 | 33 | 0.820 |
Why?
|
| Medication Errors | 1 | 2021 | 39 | 0.810 |
Why?
|
| Health Personnel | 1 | 2023 | 202 | 0.810 |
Why?
|
| Critical Care | 4 | 2019 | 370 | 0.810 |
Why?
|
| Ketosis | 1 | 2021 | 9 | 0.800 |
Why?
|
| Aminopyridines | 1 | 2021 | 38 | 0.780 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2021 | 51 | 0.780 |
Why?
|
| Triazines | 1 | 2021 | 53 | 0.770 |
Why?
|
| Diagnosis, Differential | 7 | 2019 | 1565 | 0.720 |
Why?
|
| Publications | 1 | 2020 | 27 | 0.720 |
Why?
|
| Thiamine Deficiency | 1 | 2019 | 4 | 0.700 |
Why?
|
| Acidosis, Lactic | 1 | 2019 | 12 | 0.700 |
Why?
|
| Patient Safety | 2 | 2020 | 212 | 0.700 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2019 | 8 | 0.690 |
Why?
|
| Shock | 1 | 2019 | 42 | 0.690 |
Why?
|
| Cardiologists | 1 | 2019 | 4 | 0.690 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2021 | 199 | 0.690 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2020 | 67 | 0.680 |
Why?
|
| Syncope | 2 | 2016 | 34 | 0.680 |
Why?
|
| Vena Cava, Superior | 1 | 2019 | 59 | 0.670 |
Why?
|
| Intention | 1 | 2019 | 51 | 0.660 |
Why?
|
| Catheters | 1 | 2019 | 74 | 0.660 |
Why?
|
| Range of Motion, Articular | 1 | 2019 | 154 | 0.650 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 639 | 0.640 |
Why?
|
| Patient Care | 1 | 2019 | 100 | 0.630 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2017 | 16 | 0.610 |
Why?
|
| Medical Staff, Hospital | 2 | 2019 | 107 | 0.610 |
Why?
|
| Dizziness | 1 | 2017 | 27 | 0.600 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 141 | 0.600 |
Why?
|
| Head Movements | 1 | 2017 | 39 | 0.600 |
Why?
|
| Streptococcal Infections | 1 | 2017 | 57 | 0.580 |
Why?
|
| Vena Cava Filters | 1 | 2018 | 96 | 0.580 |
Why?
|
| Clinical Clerkship | 1 | 2018 | 116 | 0.580 |
Why?
|
| Marketing of Health Services | 1 | 2016 | 15 | 0.580 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2016 | 21 | 0.570 |
Why?
|
| Students, Medical | 2 | 2018 | 384 | 0.550 |
Why?
|
| Brain Diseases | 1 | 2017 | 180 | 0.540 |
Why?
|
| Renal Dialysis | 1 | 2019 | 355 | 0.540 |
Why?
|
| Patient Care Team | 2 | 2018 | 280 | 0.530 |
Why?
|
| Hemodynamics | 1 | 2019 | 710 | 0.530 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 344 | 0.530 |
Why?
|
| Education, Medical, Graduate | 2 | 2018 | 369 | 0.530 |
Why?
|
| Psychotic Disorders | 1 | 2017 | 184 | 0.520 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 426 | 0.520 |
Why?
|
| Social Media | 1 | 2016 | 79 | 0.520 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 763 | 0.510 |
Why?
|
| Inpatients | 2 | 2018 | 297 | 0.510 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 295 | 0.510 |
Why?
|
| Health Promotion | 1 | 2016 | 160 | 0.500 |
Why?
|
| Hospitalization | 1 | 2019 | 849 | 0.460 |
Why?
|
| Thrombolytic Therapy | 3 | 2020 | 220 | 0.440 |
Why?
|
| Asthma | 1 | 2019 | 955 | 0.380 |
Why?
|
| Retrospective Studies | 5 | 2022 | 8489 | 0.370 |
Why?
|
| Quality of Health Care | 1 | 2014 | 380 | 0.370 |
Why?
|
| Medical Overuse | 2 | 2020 | 36 | 0.350 |
Why?
|
| Resuscitation | 2 | 2020 | 100 | 0.340 |
Why?
|
| Internship and Residency | 4 | 2019 | 1004 | 0.320 |
Why?
|
| Hypertension | 1 | 2016 | 1141 | 0.310 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2019 | 134 | 0.300 |
Why?
|
| Hospitals | 2 | 2020 | 294 | 0.290 |
Why?
|
| Cohort Studies | 2 | 2023 | 2767 | 0.260 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1721 | 0.260 |
Why?
|
| Prognosis | 2 | 2023 | 3679 | 0.240 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 48 | 0.230 |
Why?
|
| Aged | 4 | 2021 | 18415 | 0.220 |
Why?
|
| Middle Aged | 6 | 2019 | 25028 | 0.220 |
Why?
|
| Female | 9 | 2021 | 44532 | 0.210 |
Why?
|
| Risk Assessment | 2 | 2020 | 2261 | 0.210 |
Why?
|
| Medication Reconciliation | 1 | 2021 | 6 | 0.210 |
Why?
|
| Pharmacists | 1 | 2021 | 32 | 0.200 |
Why?
|
| Histiocytic Sarcoma | 1 | 2021 | 8 | 0.200 |
Why?
|
| Male | 6 | 2021 | 40965 | 0.190 |
Why?
|
| United States Agency for Healthcare Research and Quality | 1 | 2020 | 6 | 0.190 |
Why?
|
| Causality | 1 | 2020 | 81 | 0.180 |
Why?
|
| Patient Acuity | 1 | 2019 | 32 | 0.180 |
Why?
|
| Organ Dysfunction Scores | 1 | 2019 | 27 | 0.180 |
Why?
|
| Lactates | 1 | 2019 | 37 | 0.180 |
Why?
|
| Thiamine | 1 | 2019 | 8 | 0.180 |
Why?
|
| Risk Factors | 2 | 2020 | 5417 | 0.170 |
Why?
|
| Contraceptives, Oral | 1 | 2019 | 46 | 0.170 |
Why?
|
| Diagnosis | 1 | 2018 | 14 | 0.170 |
Why?
|
| Lactic Acid | 1 | 2019 | 90 | 0.170 |
Why?
|
| Chest Pain | 1 | 2019 | 42 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 2601 | 0.170 |
Why?
|
| Dyspnea | 1 | 2019 | 73 | 0.170 |
Why?
|
| Community-Acquired Infections | 1 | 2019 | 63 | 0.170 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 98 | 0.160 |
Why?
|
| Treatment Failure | 1 | 2019 | 285 | 0.160 |
Why?
|
| Electronic Health Records | 1 | 2021 | 319 | 0.160 |
Why?
|
| Stroke Volume | 1 | 2020 | 456 | 0.160 |
Why?
|
| Qualitative Research | 1 | 2019 | 256 | 0.150 |
Why?
|
| Pneumonia | 1 | 2019 | 179 | 0.150 |
Why?
|
| Hospitalists | 1 | 2019 | 131 | 0.150 |
Why?
|
| Terminology as Topic | 1 | 2018 | 217 | 0.150 |
Why?
|
| Radiography, Thoracic | 1 | 2019 | 320 | 0.150 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 298 | 0.150 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2017 | 92 | 0.150 |
Why?
|
| Direct-to-Consumer Advertising | 1 | 2016 | 1 | 0.150 |
Why?
|
| Bias | 1 | 2017 | 127 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2018 | 143 | 0.150 |
Why?
|
| Professionalism | 1 | 2016 | 24 | 0.140 |
Why?
|
| Cerebral Angiography | 1 | 2017 | 196 | 0.140 |
Why?
|
| Thrombosis | 1 | 2019 | 296 | 0.140 |
Why?
|
| Spinal Fusion | 1 | 2017 | 85 | 0.140 |
Why?
|
| Registries | 1 | 2020 | 702 | 0.140 |
Why?
|
| Immunoglobulins | 1 | 2017 | 148 | 0.140 |
Why?
|
| Syndrome | 1 | 2017 | 446 | 0.140 |
Why?
|
| Patient Discharge | 1 | 2019 | 300 | 0.140 |
Why?
|
| Sex Factors | 1 | 2019 | 1054 | 0.140 |
Why?
|
| Fluid Therapy | 1 | 2016 | 50 | 0.140 |
Why?
|
| Family Practice | 1 | 2016 | 84 | 0.140 |
Why?
|
| Feasibility Studies | 1 | 2018 | 751 | 0.140 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 263 | 0.130 |
Why?
|
| Teaching | 1 | 2016 | 147 | 0.130 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 763 | 0.130 |
Why?
|
| Ultrasonography | 1 | 2016 | 695 | 0.120 |
Why?
|
| Atrioventricular Block | 1 | 2013 | 23 | 0.110 |
Why?
|
| Recurrence | 1 | 2016 | 1139 | 0.110 |
Why?
|
| Heart Ventricles | 1 | 2018 | 760 | 0.110 |
Why?
|
| Cognition | 1 | 2017 | 570 | 0.110 |
Why?
|
| Prospective Studies | 2 | 2018 | 4213 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1036 | 0.110 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2013 | 159 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 454 | 0.100 |
Why?
|
| Age Factors | 1 | 2016 | 1851 | 0.100 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2013 | 206 | 0.100 |
Why?
|
| Electrocardiography | 1 | 2013 | 478 | 0.100 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 610 | 0.100 |
Why?
|
| Adult | 3 | 2021 | 25648 | 0.100 |
Why?
|
| United States | 1 | 2020 | 6672 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2017 | 7993 | 0.060 |
Why?
|
| Meningitis | 1 | 2021 | 20 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2021 | 293 | 0.050 |
Why?
|
| Monocytes | 1 | 2021 | 214 | 0.040 |
Why?
|
| Patients | 1 | 2019 | 100 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2019 | 197 | 0.040 |
Why?
|
| Wisconsin | 1 | 2016 | 39 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 1 | 2013 | 83 | 0.030 |
Why?
|
| Curriculum | 1 | 2016 | 539 | 0.030 |
Why?
|
| Heart Rate | 1 | 2013 | 492 | 0.020 |
Why?
|